Related Experiment Video
Updated: Feb 25, 2026

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Solid lipid nanoparticles improve octyl gallate antimetastatic activity and ameliorate its renal and hepatic toxic
Clarissa A S Cordova1, Claudriana Locatelli, Evelyn Winter
1aDepartment of Pharmaceutical Sciences bDepartment of Biochemistry cDepartment of Chemistry, Federal University of Santa Catarina dNanovetores Technology S.A., Florianópolis eUniversity of Western Santa Catarina, Videira, SC fFederal University of Tocantins, Araguaína, TO, Brazil.
Abstract:
Metastasis is the main cause of cancer-related death and requires the development of effective treatments with reduced toxicity and effective anticancer activity. Gallic acid derivatives have shown significant biological properties including antitumoral activity as shown in a previous study with octyl gallate (G8) in vitro. Thus, the aim of this work was to evaluate the antimetastatic effect of free and solid lipid nanoparticle-loaded G8 in mice in a lung metastasis model. Animals inoculated with melanoma cells presented metastasis in lungs, which was significantly inhibited by treatment with G8 and solid lipid nanoparticle-loaded G8, named G8-NVM. However, G8-treated mice showed an increase in several toxicological parameters, which were almost completely circumvented by G8-NVM treatment. This study supports the need for pharmacological studies on new potential medicinal plants to treat cancer and can provide new perspectives on using nanotechnology to improve biological activities while decreasing the chemotherapy toxicological effects of anticancer drugs.
Insights
Octyl gallate (G8) and its nanoparticle formulation (G8-NVM) effectively inhibited lung metastasis in mice. G8-NVM significantly reduced cancer spread and toxicity compared to free G8, offering a promising anticancer strategy.
Area of Science:
- Oncology
- Nanotechnology
- Pharmacology
Background:
- Metastasis is a primary cause of cancer mortality, necessitating novel treatments with improved efficacy and reduced toxicity.
- Gallic acid derivatives, such as octyl gallate (G8), possess demonstrated antitumoral properties.
- Developing effective anticancer therapies with lower side effects is crucial.
Purpose of the Study:
- To evaluate the antimetastatic potential of free octyl gallate (G8) and solid lipid nanoparticle-loaded G8 (G8-NVM).
- To assess the toxicological profile of G8 and G8-NVM in a murine lung metastasis model.
Main Methods:
- Melanoma cells were inoculated into mice to establish a lung metastasis model.
- Mice were treated with free G8 or G8-NVM.
- Metastasis inhibition and toxicological parameters were evaluated.
Main Results:
- Both G8 and G8-NVM treatments significantly inhibited lung metastasis.
- G8 treatment led to increased toxicological parameters in mice.
- G8-NVM treatment largely circumvented the toxic effects observed with free G8.
Conclusions:
- Octyl gallate exhibits antimetastatic activity, which can be enhanced and made safer through nanotechnology.
- Solid lipid nanoparticle formulation of G8 (G8-NVM) offers a promising approach to reduce chemotherapy-related toxicity while maintaining anticancer efficacy.
- Further research into plant-derived compounds and nanotechnology is warranted for improved cancer treatment strategies.
Related Concept Videos
Bioavailability Enhancement: Drug Permeability Enhancement
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

